FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/02/012121 [Registered on: 23/02/2018] Trial Registered Prospectively
Last Modified On: 11/04/2022
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Sai Vibrionics and Primordial Sound Chanting]  
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Study the effect of two health and wellness therapies during and after pregnancy 
Scientific Title of Study   ANIRVID: A multi-center study to evaluate the effect of complimentary alternative interventions on perinatal depression and its associated heart and thyroid function using conventional techniques, metabolomics and point of care device. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sai Sathish Ramamurthy 
Designation  Principal Investigator 
Affiliation  Sri Sathya Sai Institute of Higher Learning 
Address  Department of Chemistry Sri Sathya Sai Institute of Higher Learning Prasanthi Nilayam campus, Puttaparthi, Anantapur District

Anantapur
ANDHRA PRADESH
515134
India 
Phone  8790314405  
Fax    
Email  rsaisathish@sssihl.edu.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sai Sathish Ramamurthy 
Designation  Principal Investigator 
Affiliation  Sri Sathya Sai Institute of Higher Learning 
Address  Department of Chemistry Sri Sathya Sai Institute of Higher Learning Prasanthi Nilayam campus, Puttaparthi, Anantapur District


ANDHRA PRADESH
515134
India 
Phone  8790314405  
Fax    
Email  rsaisathish@sssihl.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr Sai Sathish Ramamurthy 
Designation  Principal Investigator 
Affiliation  Sri Sathya Sai Institute of Higher Learning 
Address  Department of Chemistry Sri Sathya Sai Institute of Higher Learning Prasanthi Nilayam campus, Puttaparthi, Anantapur District


ANDHRA PRADESH
515134
India 
Phone  8790314405  
Fax    
Email  rsaisathish@sssihl.edu.in  
 
Source of Monetary or Material Support  
Tata Education and Development Trust c/o. Sri Ratan Tata Trust, Bombay House, Homi Mody Street, Fort, Mumbai 400001 Tel.: 022-66658282 
 
Primary Sponsor  
Name  Tata Education and Development Trust 
Address  c/o. Sri Ratan Tata Trust, Bombay House, Homi Mody Street, Fort, Mumbai 400001 Tel.: 022-6665 8282 Fax: 022-6665 8013 
Type of Sponsor  Other [Private Funding Agency] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 4  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Madras Loukya  Sri Sathya Sai General Hospital  Room No. 6, Ground Floor, Department of Obstetrics and Gynaecology, Prasanthi Nilayam, Puttaparthi-515134
Anantapur
ANDHRA PRADESH 
8374777665

drloukya@gmail.com 
Dr Akkamahadevi C Hiremath  Sri Sathya Sai General Hospital, Sri Sathya Sai Institute of Higher Medical Sciences  Room No. G918, Ground Floor, Department of Obstetrics and Gynaecology, EPIP Area, Whitefield, Bangalore-560066
Bangalore
KARNATAKA 
9448434567

akkuch@yahoo.co.in 
Dr Gautam Rege  Sri Sathya Sai Institute of Higher Medical Sciences  Department of Cardiology, SSSIHMS, Prasanthi Gram, Puttaparthi 515134
Anantapur
ANDHRA PRADESH 
9890787417

gautam.rege@sssihms.org.in 
Dr Srikanth Sola  Sri Sathya Sai Institute of Higher Medical Sciences  Department of Cardiology, SSSIHMS,EPIP Area, Whitefield, Bangalore - 560 066
Bangalore
KARNATAKA 
9986827319

srikanth.sola@sssihms.org.in 
 
Details of Ethics Committee  
No of Ethics Committees= 4  
Name of Committee  Approval Status 
Institutional Ethics Committee of Sri Sathya Sai Institute of Higher Learning  Approved 
Institutional Ethics Committee of Sri Sathya Sai Institute of Higher Learning  Approved 
Institutional Ethics Committee of Sri Sathya Sai Institute of Higher Learning  Approved 
Institutional Ethics Committee of Sri Sathya Sai Institute of Higher Learning  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Depression and its related thyroid and heart function, during and after pregnancy,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Control group  No placebo and no complementary alternative interventions. Only standard care of treatment 
Comparator Agent  Placebo  Dosage: QDS for 1 month then TDS till delivery; after delivery TDS for 6-8 weeks. Dose: 1 sugar pill of size 30 without infusing with Subtle vibrations Above dose and dosage is in addition to standard care of treatment 
Intervention  Primordial Sound Chanting  Chant daily twice till 6-8 weeks after delivery. 10 mins in the mornings and 10 mins in the evenings. In addition to standard care of treatment above chanting regime will be administered 
Intervention  Sai Vibrionics (Placebo with subtle vibrations)  Dosage: QDS for 1 month then TDS till delivery; after delivery TDS for 6-8 weeks. Dose: 1 sugar pill of size 30 infused with subtle Vibrations Above dose and dosage is in addition to standard care of treatment 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  Pregnant Women in the age: ≥18 years and ≤40 years 
 
ExclusionCriteria 
Details  Pregnant women who are already on psychotropic medication; and Pregnant women who are already taking any complementary and alternative interventions 
 
Method of Generating Random Sequence   Stratified block randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Biomarker based point-of-care device to monitor perinatal depression, cardiac and thyroid functions, mainly in resource limited settings

Use of simple, effective, drug-free and cost-effective complementary and alternative medicine for pregnant women 
3 years 
 
Secondary Outcome  
Outcome  TimePoints 
This study will facilitate the early diagnosis and management of depression and its related disorders in pregnant women and mothers  3 years 
 
Target Sample Size   Total Sample Size="600"
Sample Size from India="600" 
Final Enrollment numbers achieved (Total)= "348"
Final Enrollment numbers achieved (India)="348" 
Phase of Trial   N/A 
Date of First Enrollment (India)   31/05/2018 
Date of Study Completion (India) 24/03/2020 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
3 publications 1. 1. Badiya,P.K. et al., Effect of mode of administration on Edinburgh Postnatal Depression Scale in the South Indian population: A comparative study on self-administered and interviewer-administered scores. 66, 102890. 2021 October 21. Asian Journal of Psychiatry. 2. Badiya, P.K. et al., Task-sharing to screen perinatal depression in resource limited setting in India: Comparison of outcomes based on screening by non-expert and expert rater. 62, 102738. 2021 Aug 1. Asian Journal of Psychiatry. 3. Badiya, P.K. et al., Identification of clinical and psychosocial characteristics associated with perinatal depression in the south Indian population. 66, 161-170. 2020 Sep 1. General Hospital Psychiatry.  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Perinatal depression is highly prevalent and is a major public health issue as it affects both the mother and the newborn. In addition, several study findings implicate depression as one of the causative factors for cardiovascular disease and thyroid disorders. Therefore, early detection of depression is necessary for the benefit of both mother and child. The main goal of this proposed multi-center study is to develop a more rapid, hand-held, mobile-health point-of-care (POC) diagnostic device - ‘Anirvid’ for monitoring key biomarkers related to perinatal depression and its related disorders at low-cost than current existing systems. In addition, the efficacy of drugs-free complementary and alternative interventions on perinatal depression and its associated cardiac and thyroid functions will also be studied using ‘Sai Vibrionics’ and ‘Primordial Chanting.’ Therefore, the proposed study will facilitate early diagnosis, prognosis and modification in the management of perinatal depression for the benefit of pregnant women and mothers in the society. 
Close